| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 10999768 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 1150 journal articles in the PubMed database | Email to a friend | | |
| Ciardiello F, Bianco R, Damiano V, et al.
Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells. [Journal Article]
Clin Cancer Res 2000 Sep; 6(9):3739-47.
Abstract | Full Citation | Find Related Articles | | Ciardiello F, Caputo R, Bianco R, et al.
Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. [Journal Article]
Clin Cancer Res 2001 May; 7(5):1459-65.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Bianco C, Bianco R, Tortora G, et al.
Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide. [Journal Article]
Clin Cancer Res 2000 Nov; 6(11):4343-50.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Ciardiello F, Bianco R, Caputo R, et al.
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy. [Journal Article]
Clin Cancer Res 2004 Jan 15; 10(2):784-93.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Ciardiello F, Bianco R, Damiano V, et al.
Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225. [Journal Article]
Clin Cancer Res 1999 Apr; 5(4):909-16.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Ciardiello F, Damiano V, Bianco R, et al.
Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A. [Journal Article]
J Natl Cancer Inst 1996 Dec 4; 88(23):1770-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Perrotte P, Matsumoto T, Inoue K, et al.
Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice. [Journal Article]
Clin Cancer Res 1999 Feb; 5(2):257-65.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Bruns CJ, Harbison MT, Davis DW, et al.
Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. [Journal Article]
Clin Cancer Res 2000 May; 6(5):1936-48.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Ciardiello F, Caputo R, Damiano V, et al.
Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase. [Journal Article]
Clin Cancer Res 2003 Apr; 9(4):1546-56.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
